BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21621523)

  • 1. Human papillomavirus 16E6 suppresses major histocompatibility complex class I by upregulating lymphotoxin expression in human cervical cancer cells.
    Kim DH; Kim EM; Lee EH; Ji KY; Yi J; Park M; Kim KD; Cho YY; Kang HS
    Biochem Biophys Res Commun; 2011 Jun; 409(4):792-8. PubMed ID: 21621523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
    Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
    Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter.
    Li H; Ou X; Xiong J; Wang T
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
    Wang JT; Ding L; Gao ES; Cheng YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.
    Daemen T; Pries F; Bungener L; Kraak M; Regts J; Wilschut J
    Gene Ther; 2000 Nov; 7(21):1859-66. PubMed ID: 11110419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
    Yamato K; Yamada T; Kizaki M; Ui-Tei K; Natori Y; Fujino M; Nishihara T; Ikeda Y; Nasu Y; Saigo K; Yoshinouchi M
    Cancer Gene Ther; 2008 Mar; 15(3):140-53. PubMed ID: 18157144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
    Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
    Nimako M; Fiander AN; Wilkinson GW; Borysiewicz LK; Man S
    Cancer Res; 1997 Nov; 57(21):4855-61. PubMed ID: 9354449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.
    Valdespino V; Gorodezky C; Ortiz V; Kaufmann AM; Roman-Basaure E; Vazquez A; Berumen J
    Gynecol Oncol; 2005 Jan; 96(1):92-102. PubMed ID: 15589586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
    Donalisio M; Cornaglia M; Landolfo S; Lembo D
    Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.